Skip to main content
Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · IEX Real-Time Price · USD
9.18
+0.44 (5.03%)
At close: May 2, 2024, 4:00 PM
9.46
+0.28 (3.05%)
After-hours: May 2, 2024, 7:58 PM EDT

Vir Biotechnology Revenue

In the year 2023, Vir Biotechnology had annual revenue of $86.18M, a decrease of -94.67%. Revenue in the quarter ending December 31, 2023 was $16.79M, a -66.03% decrease year-over-year.

Revenue (ttm)
$86.18M
Revenue Growth
-94.67%
P/S Ratio
14.47
Revenue / Employee
$146,814
Employees
587
Market Cap
1.25B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Collegium Pharmaceutical 566.77M
AtriCure 399.25M
Phreesia 356.30M
MannKind 198.96M
Mirum Pharmaceuticals 186.37M
Gyre Therapeutics 113.45M
Prothena Corporation 91.37M
Revenue Rankings

VIR News

More News